Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
CIRCULATION: Call for Papers on COVID-19
03/20/2020 | CIRCULATION Call for Papers on COVID-19
CIRCULATION Editor's Picks | Feb/March 2020
03/19/2020 | CIRCULATON Editor's Picks for January 2020
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
Exercise-Related Acute Cardiovascular Events & Potential Deleterious Adaptations
02/26/2020 | The benefits of regular moderate-to-vigorous physical activity (PA), and the associated improvements in cardiorespiratory fitness (CRF), far outweigh the risks for most individuals.
Circulation: Cardiovascular Imaging | Twitter Journal Club | Feb 28, 12-1 pm EST
02/24/2020 | Circulation: Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies
Public Comment: 2020 ACC/AHA Performance Measures for Adult with Heart Failure
02/07/2020 | We would like to invite you to participate in the review of the draft version of the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults with Heart Failure.
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.